On Friday, TASER International, Inc (NASDAQ:TASR)’s shares declined -1.20% to $27.07, as TASER International, Inc (TASR), declared the purchase of 178 AXON body-worn video cameras and a one-year subscription to EVIDENCE.com by the City of London Police Department. This order was received and shipped in the first quarter of 2015.
“The City of London is presently undergoing a transformation in how we use technology to assist us with keeping the City safe,” said Chief Superintendent Dave Lawes of the City of London. “We’re excited about TASER’s end-to-end solution that allows our police force the flexibility to integrate with existing and future technology.”
“The City of London is truly innovative in their approach to building a premier body-worn video and digital evidence program in the UK,” says Rick Smith, founder and CEO of TASER International. “We’re looking forward to working with them and other police forces in the UK to assist build safer communities with our turn-key technology solution.”
TASER International, Inc. develops, manufactures, and sells conducted electrical weapons (CEWs) worldwide. It operates through two segments, TASER Weapons and AXON. The corporation’s CEW products transmit electrical pulses along the wires and into the body affecting the sensory and motor functions of the peripheral nervous system. It offers three hand-held CEW product lines, counting TASER X26P and TASER X2, which integrates with EVIDENCE.com; and TASER X26.
Fiserv Inc (NASDAQ:FISV)’s shares dropped -1.19% to $79.06, during the last trading session on Friday, on April 6, Fiserv Inc (FISV), declared that E-Central Credit Union, based in Pasadena, California, has selected the XP2® core processing platform in an outsourced deployment. The credit union will also implement several integrated digital solutions, counting Corillian Online® for online banking, Mobiliti™ for mobile banking, CheckFree® RXP® for electronic bill payments, Mobile Source Capture™ for mobile check deposit, and Wisdom™ for comprehensive accounting functionality.
Founded on New Year’s Day in 1943, E-Central Credit Union has about $161 million in assets and 17,000 members. After a competitive review process, the 72-year-old credit union selected Fiserv to upgrade its core technology to drive growth by reducing overall cost, increasing operational efficiency, mitigating risk and enhancing new and current member relationships.
“Credit unions rely on our solutions to compriseently deliver high-value services that strengthen member satisfaction, loyalty and profitability,” said Mark Sievewright, president, Credit Union Solutions, Fiserv. “E-Central Credit Union’s selection of XP2 from Fiserv demonstrates the value of our continued commitment and investment in technology for progressive credit unions. With the addition of digital channels and payments solutions from Fiserv, E-Central is positioned to deliver advanced financial services efficiently and effectively, enhancing member relationships both now and in the future.”
Fiserv, Inc., together with its auxiliaries, provides financial services technology worldwide. The corporation’s Payments and Industry Products segment provides debit, credit, and prepaid card processing and services; electronic bill payment and presentment services; Internet and mobile banking software and services; person-to-person payment services; and other electronic payments software and services.
At the end of Friday’s trade, StemCells Inc (NASDAQ:STEM)‘s shares dipped -1.19% to $0.998, soon after StemCells Inc (STEM), declared that Martin McGlynn, CEO of StemCells, Inc., will make a presentation on the Corporation’s programs and operations at the 14th Annual Needham Healthcare Conference. Administration is planned to speak at 3:40 p.m. Eastern Daylight Time on Wednesday, April 15, at The Westin NY Grand Central Hotel located at 212 E 42nd Street in NYC.
StemCells, Inc., a biopharmaceutical corporation, researches, develops, and commercializes cell-based therapeutics and related technologies for stem cell-based research and drug discovery and development. It engages in clinical development of its platform technology, HuCNS-SC, a purified human neural stem cells used as a potential treatment for disorders of the central nervous system. The corporation has accomplished Phase I/II clinical trial for the treatment of chronic spinal cord injury; and Phase I clinical trial for the treatment of Pelizaeus-Merzbacher disease, in addition to accomplished enrollment and treatment in its Phase I/II clinical trial in geographic atrophy of age-related macular degeneration that cause blindness in the elderly. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.
Pioneer Natural Resources (NYSE:PXD), ended its Friday’s trading session with -1.19% loss, and closed at $172.52, after Pioneer Natural Resources (PXD), declared that Tim Dove, President and Chief Operations Officer, will present at The Independent Petroleum Association of America (IPAA) Oil & Gas Investment Symposium on Tuesday, April 21, 2015 at 2:25 p.m. Eastern.
Pioneer Natural Resources Corporation engages in the exploration and production of oil and gas in the United States. The corporation produces and sells oil, natural gas liquids (NGLs), and gas. It has operations primarily in the Permian Basin in West Texas, the Eagle Ford Shale play in South Texas, the Raton field in southeastern Colorado, and the West Panhandle field in the Texas Panhandle.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
